<bill session="108" type="h" number="5155" updated="2023-01-13T22:01:45Z">
  <state datetime="2004-09-28">REFERRED</state>
  <status>
    <introduced datetime="2004-09-28"/>
  </status>
  <introduced datetime="2004-09-28"/>
  <titles>
    <title type="display">Free Market Drug Act</title>
    <title type="official" as="introduced">To establish the National Institute for Biomedical Research and Development.</title>
    <title type="short" as="introduced">Free Market Drug Act</title>
  </titles>
  <sponsor bioguide_id="K000336"/>
  <cosponsors>
    <cosponsor bioguide_id="C000380" joined="2004-11-17"/>
    <cosponsor bioguide_id="C000714" joined="2004-09-28"/>
    <cosponsor bioguide_id="D000096" joined="2004-09-28"/>
    <cosponsor bioguide_id="G000551" joined="2004-09-28"/>
    <cosponsor bioguide_id="H000627" joined="2004-10-07"/>
    <cosponsor bioguide_id="J000283" joined="2004-09-28"/>
    <cosponsor bioguide_id="L000551" joined="2004-09-28"/>
    <cosponsor bioguide_id="O000159" joined="2004-09-28"/>
    <cosponsor bioguide_id="S000248" joined="2004-09-28"/>
  </cosponsors>
  <actions>
    <action datetime="2004-09-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2004-09-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2004-10-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Awards, medals, prizes"/>
    <term name="Citizen lawsuits"/>
    <term name="Commemorations"/>
    <term name="Commerce"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Economics and Public Finance"/>
    <term name="Electronic government information"/>
    <term name="Executive reorganization"/>
    <term name="Federal aid to research"/>
    <term name="Finance and Financial Sector"/>
    <term name="Government Operations and Politics"/>
    <term name="Government contractors"/>
    <term name="Government paperwork"/>
    <term name="Government property"/>
    <term name="Government publicity"/>
    <term name="Injunctions"/>
    <term name="Intellectual property"/>
    <term name="Internet"/>
    <term name="Law"/>
    <term name="Legal fees"/>
    <term name="Licenses"/>
    <term name="Medical laboratories"/>
    <term name="Medical research"/>
    <term name="Medical supplies"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Parties to actions"/>
    <term name="Patents"/>
    <term name="Performance measurement"/>
    <term name="Pharmaceutical research"/>
    <term name="Planning"/>
    <term name="Prescription pricing"/>
    <term name="Research and development"/>
    <term name="Research centers"/>
    <term name="Research grants"/>
    <term name="Science, Technology, Communications"/>
    <term name="Surety and fidelity"/>
    <term name="Web sites"/>
  </subjects>
  <amendments/>
  <summary date="2004-11-30T19:37:16Z" status="Introduced in House">Free Market Drug Act - Establishes the National Institute for Biomedical Research and Development to provide for the development of drugs, biological products, and devices to: (1) increase the number and medical efficacy of drugs, biological products, and devices on the market; and (2) make the drugs, biological products, and devices available to the public at reasonable prices.

Requires the Director of the Institute to: (1) monitor the results of certain research to identify discoveries that, if subjected to appropriate research and development activities, may be suitable for approval by the Food and Drug Administration (FDA) as drugs, biological products, or devices for use in humans (candidate discoveries); (2) identify candidate discoveries and carry out appropriate research and development regarding such discoveries; (3) establish, review, and revise a plan for the development, testing, and manufacture of candidate discoveries through the Institute; (4) establish priorities among candidate discoveries; and (5)) maintain an Internet site to make available to the public information on activities under this Act.

Allows the Director to identify a discovery as a candidate discovery only if the Federal Government holds, or can reasonably be expected to obtain, a patent on the discovery. Prohibits the Director from transferring ownership of such patent to any non-Federal entity.

Allows civil suits to protect Federal ownership of patents.

Requires the Director to: (1) grant non-exclusive licenses for the commercial marketing of FDA-approved candidate discoveries; (2) establish Federal laboratories to carry out this Act; and (3) establish a fund to provide cash awards for making significant advances in knowledge regarding a disease, disorder, or other health condition.</summary>
</bill>
